Free Trial
NASDAQ:TRAW

Traws Pharma (TRAW) Stock Price, News & Analysis

Traws Pharma logo
$1.43 -0.03 (-2.05%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$1.48 +0.05 (+3.15%)
As of 07/3/2025 04:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Traws Pharma Stock (NASDAQ:TRAW)

Key Stats

Today's Range
$1.43
$1.50
50-Day Range
$1.10
$1.87
52-Week Range
$0.97
$19.44
Volume
57,254 shs
Average Volume
450,641 shs
Market Capitalization
$7.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Traws Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

TRAW MarketRank™: 

Traws Pharma scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Traws Pharma.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Traws Pharma is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Traws Pharma is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Traws Pharma's valuation and earnings.
  • Percentage of Shares Shorted

    7.91% of the float of Traws Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Traws Pharma has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Traws Pharma has recently increased by 273.67%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Traws Pharma does not currently pay a dividend.

  • Dividend Growth

    Traws Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.91% of the float of Traws Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Traws Pharma has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Traws Pharma has recently increased by 273.67%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Traws Pharma has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Traws Pharma this week, compared to 1 article on an average week.
  • Search Interest

    Only 1 people have searched for TRAW on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Traws Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    13.60% of the stock of Traws Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 7.95% of the stock of Traws Pharma is held by institutions.

  • Read more about Traws Pharma's insider trading history.
Receive TRAW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Traws Pharma and its competitors with MarketBeat's FREE daily newsletter.

TRAW Stock News Headlines

Traws Pharma announces chief financial officer transition
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

TRAW Stock Analysis - Frequently Asked Questions

Traws Pharma's stock was trading at $8.88 at the start of the year. Since then, TRAW shares have decreased by 83.9% and is now trading at $1.43.

Traws Pharma, Inc. (NASDAQ:TRAW) posted its quarterly earnings results on Thursday, May, 15th. The company reported $2.09 earnings per share for the quarter, topping the consensus estimate of ($8.04) by $10.13. The business had revenue of $0.06 million for the quarter, compared to analysts' expectations of $0.06 million.

Shares of TRAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Traws Pharma investors own include Clearside Biomedical (CLSD), Evofem Biosciences (EVFM), Nikola (NKLA), Palatin Technologies (PTN), Sirius XM (SIRI), Adverum Biotechnologies (ADVM) and Aptinyx (APTX).

Company Calendar

Last Earnings
5/15/2025
Today
7/06/2025
Next Earnings (Estimated)
8/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TRAW
Previous Symbol
NASDAQ:TRAW
Employees
17
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$166.52 million
Net Margins
-15,245.81%
Pretax Margin
-61,696.04%

Debt

Sales & Book Value

Annual Sales
$227 thousand
Price / Cash Flow
N/A
Book Value
($8.66) per share
Price / Book
-0.17

Miscellaneous

Free Float
4,807,000
Market Cap
$7.96 million
Optionable
Optionable
Beta
1.46
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:TRAW) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners